Fund investigators from under-represented communities and community sites to lead trials
Patients are more likely to join a trial when the doctor offering it looks like them or works in their community. Funding more such doctors to become trial leaders would change who is enrolled.
Career development awards, protected time and mentorship for oncologists from under-represented groups and those practising in community, rural and safety-net settings, tied to becoming principal investigators. Cooperative groups set targets for the share of PIs from these backgrounds. Evidence that racial concordance and community-based investigators raise minority enrolment is observational but consistent.
- Trials do not represent the people who get cancer · Older, Black, Hispanic, Asian, rural, poor and multimorbid patients are under-represented, so results may not apply to them.
- Not enough oncologists, nurses, pathologists, physicists · The number of people with cancer is rising faster than the workforce trained to treat them.
Pages like this
not linked directly; found by shared links- IdeaA public equity index for trial sites and sponsors, tied to funding
Shares American Society of Clinical Oncology (ASCO), Trials do not represent the people who get cancer, National Cancer Institute (NIH).
- IdeaLay trial navigators funded per centre, evaluated in a randomised trial
Shares American Society of Clinical Oncology (ASCO), Trials do not represent the people who get cancer, National Cancer Institute (NIH).
- IdeaStop excluding people with a prior cancer, controlled HIV, or treated hepatitis
Shares American Society of Clinical Oncology (ASCO), Trials do not represent the people who get cancer, National Cancer Institute (NIH).
- IdeaDefault-inclusive eligibility: sponsors must justify every exclusion criterion
Shares American Society of Clinical Oncology (ASCO), Trials do not represent the people who get cancer, National Cancer Institute (NIH).
- IdeaCommunity health workers and trusted local organisations paid to recruit for trials
Shares Trials do not represent the people who get cancer, National Cancer Institute (NIH).
- IdeaAt least a third of pivotal-trial sites in community and rural settings
Shares Trials do not represent the people who get cancer, National Cancer Institute (NIH).
- IdeaRemove blanket exclusions for mental illness and dementia; support consent instead
Shares Trials do not represent the people who get cancer, National Cancer Institute (NIH).
- IdeaMobile research units bring trial visits to rural towns
Shares Trials do not represent the people who get cancer, National Cancer Institute (NIH).